Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 20, 2021 - Issue 4
Submit an article Journal homepage
313
Views
12
CrossRef citations to date
0
Altmetric
Review

The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability

Anastasios G. Konstasa 1st and 3rd University Departments of Ophthalmology, Aristotle University of Thessaloniki, Thessaloniki, GreeceCorrespondence[email protected]
View further author information
,
Antoine Labbéb Department of Ophthalmology III, Quinze-Vingts Hospital, Paris, France;Quinze-Vingts Hospital, Paris, France; Inserm, ; RUPMC Univ Paris 06, Institut De La Vision; CNRS, ; CHNO Des Quinze-Vingts, INSERM-DHOS Paris, France; Department of Ophthalmology, Ambroise Paré Hospital, AP-HP, University of Versailles Saint-Quentin-en-Yvelines, Versailles, FranceView further author information
,
Andreas Katsanosc Ophthalmology Department, University of Ioannina, Ioannina, GreeceORCID Iconhttps://orcid.org/0000-0001-6623-8503View further author information
ORCID Icon,
Frances Meier-Gibbonsd Eye Center Rapperswil, Rapperswil, SwitzerlandView further author information
,
Murat Irkece Department of Ophthalmology, Hacettepe University, Faculty of Medicine, Ankara, TurkeyView further author information
,
Konstadinos G. Boboridisf 3 Ophthalmology Department, Aristotle University of Thessaloniki, Thessaloniki, GreeceORCID Iconhttps://orcid.org/0000-0002-0471-0371View further author information
ORCID Icon,
Gábor Hollóg Department of Ophthalmology, Semmelweis University, Budapest, HungaryORCID Iconhttps://orcid.org/0000-0002-0904-4849View further author information
ORCID Icon,
Julián García-Feijooh Department of Ophthalmology, San Carlos Clinical Hospital, Health Research Institute (IdISSC), Universidad Complutense, Oftared, Madrid, SpainORCID Iconhttps://orcid.org/0000-0002-7772-5718View further author information
ORCID Icon,
Gordon N. Duttoni Department of Optometry and Visual Science, Glasgow Caledonian University, Glasgow, UKView further author information
&
Christophe Baudouinb Department of Ophthalmology III, Quinze-Vingts Hospital, Paris, France;Quinze-Vingts Hospital, Paris, France; Inserm, ; RUPMC Univ Paris 06, Institut De La Vision; CNRS, ; CHNO Des Quinze-Vingts, INSERM-DHOS Paris, France; Department of Ophthalmology, Ambroise Paré Hospital, AP-HP, University of Versailles Saint-Quentin-en-Yvelines, Versailles, FranceView further author information
 show all
Pages 453-466 | Received 19 Oct 2020, Accepted 06 Jan 2021, Published online: 21 Jan 2021

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Gábor Holló, James Kirwan, Fernando Lopez-Lopez, Marina Zimina, Claudia Fassari & Francesco Oddone. (2022) A comparison of country-level data from the VISIONARY study examining treatment outcomes with preservative-free tafluprost/timolol fixed-dose combination therapy. Current Medical Research and Opinion 38:7, pages 1189-1201.
Read now
Andreas Katsanos, Ivano Riva, Banu Bozkurt, Gábor Holló, Luciano Quaranta, Francesco Oddone, Murat Irkec, Gordon N. Dutton & Anastasios G. Konstas. (2022) A new look at the safety and tolerability of prostaglandin analogue eyedrops in glaucoma and ocular hypertension. Expert Opinion on Drug Safety 21:4, pages 525-539.
Read now
Gábor Holló, Andreas Katsanos, Konstadinos G. Boboridis, Murat Irkec & Anastasios G. Konstas. (2021) Letter to the editor: ‘topical preservative-free ophthalmic treatments an unmet clinical need’. Expert Opinion on Drug Delivery 18:4, pages 527-529.
Read now

Articles from other publishers (9)

Anastasios-Georgios Konstas, Konstadinos G. Boboridis, Georgios P. Athanasopoulos, Anna-Bettina Haidich, Irini C. Voudouragkaki, Eirini Pagkalidou, Andreas Katsanos & L. Jay Katz. (2023) Changing from preserved, to preservative-free cyclosporine 0.1% enhanced triple glaucoma therapy: impact on ocular surface disease—a randomized controlled trial. Eye 37:17, pages 3666-3674.
Crossref
Hari Jayaram, Miriam Kolko, David S Friedman & Gus Gazzard. (2023) Glaucoma: now and beyond. The Lancet 402:10414, pages 1788-1801.
Crossref
Anne Hedengran & Miriam Kolko. (2023) The molecular aspect of anti-glaucomatous eye drops - are we harming our patients?. Molecular Aspects of Medicine 93, pages 101195.
Crossref
Pinakin Gunvant Davey & Jason D. Duncan. 2023. Glaucoma - Recent Advances and New Perspectives. Glaucoma - Recent Advances and New Perspectives.
Claudia Panfil, Laure Chauchat, Camille Guerin, Hayette Rebika, Marwan Sahyoun & Norbert Schrage. (2023) Impact of Latanoprost Antiglaucoma Eyedrops and Their Excipients on Toxicity and Healing Characteristics in the Ex Vivo Eye Irritation Test System. Ophthalmology and Therapy.
Crossref
Luciano Quaranta, Alessio Novella, Mauro Tettamanti, Luca Pasina, Robert N. Weinreb & Alessandro Nobili. (2023) Adherence and Persistence to Medical Therapy in Glaucoma: An Overview. Ophthalmology and Therapy.
Crossref
Luca D'andrea, Marina Montemagni, Giuseppe Celenza, Roberto Iorio & Ciro Costagliola. (2022) Is it time for a moratorium on the use of benzalkonium chloride in eyedrops?. British Journal of Clinical Pharmacology 88:9, pages 3947-3949.
Crossref
Zoran Velkovski, Maja Belevska, Biljana Gjorgjeska & Jasmina Djordjevic-Jocic. (2022) Cost effectiveness analysis associated to the treatment of primary open-angle glaucoma according to disease severity. Srpski arhiv za celokupno lekarstvo 150:3-4, pages 177-182.
Crossref
Dai Woo Kim, Jonghoon Shin, Chang Kyu Lee, Myungjin Kim, Sohyeon Lee & Seungsoo Rho. (2021) Comparison of ocular surface assessment and adherence between preserved and preservative-free latanoprost in glaucoma: a parallel-grouped randomized trial. Scientific Reports 11:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.